arrow
E

Enrico L. DiGiammarino

discovery research
H指数:22
被引数:2,890

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

An anti-PD-1-GITR-L bispecific agonist induces GITR clustering-mediated T cell activation for cancer immunotherapy

anti-PD-1-GITR-L双特异性激动剂诱导GITR簇介导的T细胞活化用于癌症免疫治疗

2022-03-0746
OAAI
Hexavalent TRAIL Fusion Protein Eftozanermin Alfa Optimally Clusters Apoptosis-Inducing TRAIL Receptors to Induce On-Target Antitumor Activity in Solid Tumors
2021-03-0929
OA
Epitope and Fc-Mediated Cross-linking, but Not High Affinity, Are Critical for Antitumor Activity of CD137 Agonist Antibody with Reduced Liver Toxicity

表位和Fc介导的交联,但不是高亲和力,对于降低肝毒性的CD137激动剂抗体的抗肿瘤活性至关重要

2020-04-0235
OAAI
Identification of Selective Dual ROCK1 and ROCK2 Inhibitors Using Structure-Based Drug Design
2018-11-0127
OAAI
ABT-165, a Dual Variable Domain Immunoglobulin (DVD-Ig) Targeting DLL4 and VEGF, Demonstrates Superior Efficacy and Favorable Safety Profiles in Preclinical Models
2018-04-3037
OAAI
Discovery of a potent catalytic p300/CBP inhibitor that targets lineage-specific tumors
2018-01-010
PRE